Abstract:Background Cervical cancer patients have a high risk of metastasis and a poor prognosis with shorter disease-free survival. Thus, novel biomarkers and feasible therapies urgently need to be discovered. Previous studies have shown that miR-95-3p plays crucial roles in several cancer types. However, the roles of miR-95-3p in cervical cancer remain unknown. Methods The micro ribonucleic acid (miRNA) expression data and clinical characteristics of cervical cancer samples were downloaded from The Cancer Genome Atlas (TCGA) database. Univariate and multivariate Cox regression analyses were conducted to identify the prognostic-related miRNAs. The potential target genes of miR-95-3p were predicted by the TargetScan database. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted to explore the target gene of miR-95-3p. The effects of miR-95-3p inhibition and overexpression on cell proliferation were inspected by cell counting kit-8 (CCK-8) assays and cell colony formation assays. Wound-healing assays and transwell assays were also used to examine cell migration ability in HeLa and SiHa cells. Results MiR-95-3p was the only miRNA significantly associated with the poor prognosis of cervical squamous cell carcinoma. A further analysis suggested that vascular cell adhesion molecule 1 (VCAM1) is a target gene of miR-95-3p in cervical cancer, and miR-95-3p promotes the malignant behavior of cervical cancer cells by inhibiting the expression of VCAM1. The CCK-8 and cell colony assays showed that miR-95-3p downregulation significantly suppressed cell proliferation in the HeLa and SiHa cells. The transwell and wound-healing assays showed that miR-95-3p inhibition suppressed cell migration in the HeLa and SiHa cells. Further the Western blot analysis and the quantitative real-time-polymerase chain reaction (qRT-PCR) showed that the knockdown of miR-95-3p in HeLa cells resulted in increased VCAM1 expression. And VCAM1 was highly expressed in the paired adjacent normal cervical epithelium tissue samples, but lowly expressed in the cervical tumor tissue samples. Conclusions Our study was the first to show that miR-95-3p could serve as a prognostic biomarker of cervical cancer. Mechanistically, we discovered that miR-95-3p inhibited the expression of the cell adhesion molecule VCAM1 and thus promoted further tumor progression.

microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer

Downregulation of Mir-138 Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.

Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach

Roles of microRNA-486-5p in the diagnosis and the association with clinical symptoms of cervical cancer

Identification of miRNA-mRNA Regulatory Network and Construction of Prognostic Signature in Cervical Cancer

Study on serum miR-182 as a marker for diagnosis and prognosis of cervical cancer

Identification and validation of potential mRNA- microRNA- long-noncoding RNA (mRNA-miRNA-lncRNA) prognostic signature for cervical cancer

Prognostic role of microRNA-145 in various human malignant neoplasms: a meta-analysis of 18 related studies

Expression Profile Of Circulating Micrornas As A Promising Fingerprint For Cervical Cancer Diagnosis And Monitoringy

Diagnostic and Prognostic Implications of a Serum Mirna Panel in Oesophageal Squamous Cell Carcinoma.

High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer

MiR-95-3p Acts As a Prognostic Marker and Promotes Cervical Cancer Progression by Targeting VCAM1

A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma.

A microRNA–Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer

MiRNA-873-5p Acts as a Potential Novel Biomarker and Promotes Cervical Cancer Progression by Regulating ZEB1 via Notch Signaling Pathway

MicroRNAs in the Prognosis of Triple-Negative Breast Cancer

Decreased<i> miR-940</i> expression can predict a negative prognosis in early-stage nonsmoking female lung adenocarcinoma

MicroRNA-675-5p Overexpression Is an Independent Prognostic Molecular Biomarker of Short-Term Relapse and Poor Overall Survival in Colorectal Cancer

Bioinformatics analysis illustrates the functions of miR-377-5p in cervical cancer

microRNAs: New prognostic, diagnostic, and therapeutic biomarkers in cervical cancer

Appraising microRNA-99 a as a novel prognostic biomarker across 21 human cancer types based on data from the cancer genome atlas